Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000693657 | SCV000821534 | uncertain significance | Severe X-linked myotubular myopathy | 2022-04-29 | criteria provided, single submitter | clinical testing | This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 161 of the MTM1 protein (p.Val161Met). This variant is present in population databases (rs782744530, gnomAD 0.01%). This missense change has been observed in individual(s) with limb girdle muscular dystrophy (PMID: 27017278). ClinVar contains an entry for this variant (Variation ID: 572307). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Greenwood Genetic Center Diagnostic Laboratories, |
RCV002291287 | SCV002583676 | uncertain significance | not provided | 2022-09-07 | criteria provided, single submitter | clinical testing | PM2 |
Natera, |
RCV000693657 | SCV002084516 | uncertain significance | Severe X-linked myotubular myopathy | 2020-07-14 | no assertion criteria provided | clinical testing |